Moderate soreness at injection site lasting 24 hours; Moderate fatigue; This is a spontaneous report from a non-contactable consumer (patient)  A 35-years-old male patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) Lot# EH9899 on 19Jan2021 18:00 at SINGLE DOSE for Covid-19 immunization.  The patient medical history was not reported.  The patient's concomitant medications were not reported. No Covid prior vaccination. Facility where the most recent COVID-19 vaccine was hospital.  The patient experienced moderate soreness at injection site lasting 24 hours on Jan2021, moderate fatigue (12-24 hrs post injection) on Jan2021. The patient had not been tested for COVID post vaccination . Outcome of the events was unknown.  No follow-up attempts are possible.No further infromation expected.